Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).
Clinical trial NCT04428411 · COMPLETED
Trial details
- NCT number
- NCT04428411
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-05
- Primary completion
- 2020-08-30
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.